Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study
Author(s) -
Amir Wiser,
Oded Gonen,
Yehudit Ghetler,
Tal Shavit,
Arie Berkovitz,
Adrian Shulman
Publication year - 2010
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deq220
Subject(s) - dehydroepiandrosterone , medicine , randomized controlled trial , pregnancy , poor responder , pregnancy rate , gynecology , prospective cohort study , obstetrics , androgen , hormone , biology , genetics
The aim of this study was to evaluate the effect of dehydroepiandrosterone (DHEA) supplementation on in vitro fertilization (IVF) data and outcomes among poor-responder patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom